Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
Autor: | Leemans, W. F.1, Janssen, H. L. A.1, Niesters, H. G. M.2, de Man, R. A.1 r.deman@erasmusmc.nl |
---|---|
Zdroj: | Journal of Viral Hepatitis. Feb2008, Vol. 15 Issue 2, p108-114. 7p. 1 Chart, 2 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |